Latest filing published 08 Jun 2022 for Repare Therapeutics Inc., €6.4M.
Filing timeline
BuySaleInsider track record
Versant Venture Capital V, L.P.: trading record in brief
Versant Venture Capital V, L.P. discloses dealings in Repare Therapeutics Inc. to SEC (Form 4). In total, 10 filings cover trades dated from 23 March 2020 to 6 June 2022.
The open-market record consists of 1 sale worth €4.0M, with no purchase. In 2022 alone, the filings show no purchases and 1 sale.
On 8 June 2022 came the latest disclosure, a transaction for €6.4M in Repare Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 9 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Versant Venture Capital V, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 614,315 shares@ CA$14.1061.8% of flowCommon SharesTSXSEDI:3958420
- 438,795 shares@ CA$12.251738.2% of flowCommon SharesTSXSEDI:3958417
- 153,579 sharesCommon SharesTSXSEDI:3663704
- 2,054,198 sharesCommon SharesTSXSEDI:3570675
- Common SharesTSXSEDI:3570673
- 2,054,198 sharesConvertible Preferred Shares class A convertible preferred sharesTSXSEDI:3570674
- Convertible Preferred Shares class A convertible preferred sharesTSXSEDI:3570670
- 111,361 sharesConvertible Preferred Shares class B convertible preferred sharesTSXSEDI:3570676
- Convertible Preferred Shares class B convertible preferred sharesTSXSEDI:3570672
- 111,361 sharesCommon SharesTSXSEDI:3570677
10 of 10 declarations
